Examining the FDA’s Regulation of Over-the-Counter Monograph Drugs

Scheduled · Apr 1, 2025, 2:15 PM

Type: Hearing
Committees: House Energy and Commerce Subcommittee on Health
Room: 2123
Building: Rayburn House Office Building

Related bills

No related bill details are available for this meeting yet.

Witnesses

Mr. Carl D’Ruiz, MPH Senior Science, Advocacy, and Business Development Manager for Beauty and Care, North America
Mr. Scott Faber Senior Vice President, Government Affairs
Mr. Kevin Menzel Member, Board of Directors, Consumer Healthcare Products Association;
Ms. Kim Wezik, MPH Director of Advocacy
Mr. Douglas Troutman Interim Co-Chief Executive Officer